| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |